{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
AirSculpt Technologies, Inc.
AirSculpt Technologies Hits New 52-Week High of $10.80, Up 146.75%
AirSculpt Technologies, Inc. achieved a new 52-week high of USD 10.80 on October 22, 2025, reflecting a substantial increase in stock performance over the past year. The company, with a market capitalization of USD 387 million, remains unprofitable and does not offer dividends, typical for growth-stage firms.
AirSculpt Technologies Hits New 52-Week High of $10.67
AirSculpt Technologies, Inc. achieved a new 52-week high of USD 10.67 on October 15, 2025, reflecting a 156.14% increase over the past year. The company, with a market cap of USD 387 million, remains unprofitable and has a price-to-book ratio of 4.25, indicating premium valuation.
AirSculpt Technologies Hits New 52-Week High of $9.90, Up 136.87%
AirSculpt Technologies, Inc. has achieved a new 52-week high, reflecting a significant increase in stock performance with a one-year gain that notably exceeds the S&P 500. The company, valued at USD 387 million, operates in the Pharmaceuticals & Biotechnology industry and has shown substantial growth from its previous low.
AirSculpt Technologies Hits New 52-Week High of $9.77, Up 133.73%
AirSculpt Technologies, Inc. achieved a new 52-week high of USD 9.77 on October 13, 2025, reflecting a substantial increase in stock performance over the past year. The company, with a market capitalization of USD 387 million, remains unprofitable and does not offer dividends, typical for growth-stage firms.
Is AirSculpt Technologies, Inc. technically bullish or bearish?
As of August 29, 2025, AirSculpt Technologies, Inc. shows a mildly bullish trend with positive momentum from the MACD and daily moving averages, but mixed signals from the KST and OBV suggest cautious monitoring despite strong year-to-date and annual performance compared to the S&P 500.
Is AirSculpt Technologies, Inc. overvalued or undervalued?
As of August 9, 2024, AirSculpt Technologies, Inc. is considered risky and overvalued due to a negative P/E ratio, high EV to EBITDA, and poor financial metrics, with a year-to-date return of -6.55% compared to the S&P 500's 2.44%.
Is AirSculpt Technologies, Inc. technically bullish or bearish?
As of June 18, 2025, the trend is mildly bullish due to positive weekly MACD and KST indicators, though caution is warranted because daily moving averages are mildly bearish and Bollinger Bands show mixed signals.
What does AirSculpt Technologies, Inc. do?
AirSculpt Technologies, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $39 million and a net loss of $3 million as of March 2025. It has a market cap of $315.19 million and key metrics indicating a loss-making status with a debt-to-equity ratio of 0.98.
How big is AirSculpt Technologies, Inc.?
As of Jun 18, AirSculpt Technologies, Inc. has a market capitalization of 315.19 million and reported net sales of 172.10 million with a net profit of -17.13 million over the latest four quarters. Shareholder's funds are at 79.29 million, and total assets amount to 210.00 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
